Home >
News >
#ESHMPN2022 GOING VIRTUAL! SAVE THE NEW DATES
#ESHMPN2022 GOING VIRTUAL! SAVE THE NEW DATES
March 18, 2022
9th Translational Research Conference
MYELOPROLIFERATIVE NEOPLASMS
GOING VIRTUAL!
Save the new dates: May 12-15, 2022
E-Conference - #ESHMPN2022
In view of continuing COVID-19 related challenges and uncertainties,
the 9th Translational Research Conference on
MYELOPROLIFERATIVE NEOPLASMS
will be held as a VIRTUAL EVENT.
The safety of our attendees and speakers is our number one priority.
Our last 15 conferences were successfully turned into E-Conferences,
we will provide you with the best experience possible.
The E-Conference will take place from Thursday, May 12th to Sunday, May 15th, 2022.
Stay tuned,
REGISTRATION IS OPENING SOON!
About the Conference:
New insights into the molecular pathogenesis, classification, and management of patients with
Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.
The field of MPN research is rapidly expanding and consequently treatment options are changing. Clinical and laboratory investigators involved in the care of MPN patients or in research on the biology of these diseases will profit from hearing international leaders present the newest biological, clinical and therapeutic developments in the field.
The format of the scientific programme is deliberately designed to be conducive to close scientific interaction between speakers and registered participants from all over the world.
CONFERENCE MAIN TOPICS:
• Molecular pathogenesis of MPNs
• Novel MPN therapeutics
• MPN initiation and clonal evolution
• Murine MPN models and pathogenesis/therapeutic studies
• Molecular pathogenesis and therapy of MPN progression and
leukaemic transformation
• Recent advances in therapeutics
• Molecular pathogenesis of MPN
LEARNING OBJECTIVES
Upon completion of this CME activity, participants should be able:
• To understand the newest discoveries on the molecular pathogenesis of MPN
• To appreciate recent changes in treatment recommendations for MPN patients including
the evolving landscape of approved therapies
• To gain insight into ongoing clinical trials investigating novel agents for MPN treatment
• To increase knowledge about cellular and animal models of MPN and their use
for drug screening
THE PROGRAMME WILL INCLUDE:
Keynote Lectures - Plenary Sessions - Simultaneous Meet the Expert Sessions - Mentored Poster Walks
Short Oral Communications- Ample time for in-depth discussion
PRELIMINARY SCIENTIFIC PROGRAMME
MEET THE FACULTY
MORE INFORMATION
With the support of*:
Level 1 E-Conference Partner
*******
Level 2 E-Conference Partners
*******
Supporting E-Conference Partners
*******
*
ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
